The cost of manufacturing facilities for Telmisartan, including its brand name Micardis, is not publicly disclosed by manufacturers. Such information is typically considered proprietary.
What is Telmisartan used for?
Telmisartan is a medication prescribed to treat high blood pressure (hypertension) [1]. It works by relaxing blood vessels, which helps to lower blood pressure [1]. It is also used to reduce the risk of stroke, heart attack, and death from cardiovascular causes in individuals with certain conditions [1].
How does Telmisartan work?
Telmisartan belongs to a class of drugs called angiotensin II receptor blockers (ARBs) [1]. Angiotensin II is a substance in the body that narrows blood vessels, leading to increased blood pressure. Telmisartan blocks the action of angiotensin II, causing blood vessels to widen and blood pressure to decrease [1].
What is the difference between Telmisartan and Micardis?
Micardis is the brand name for the drug telmisartan [2]. Therefore, they are the same medication, with Micardis being the product marketed by the original manufacturer and telmisartan referring to the active pharmaceutical ingredient [2]. Generic versions of telmisartan are also available.
When does Telmisartan patent expire?
Patent expiry dates for specific medications can vary and are often complex, involving multiple patents covering different aspects such as the compound, formulations, and manufacturing processes [3]. DrugPatentWatch.com tracks these patent landscapes and offers detailed information on patent expiry for various drugs, including telmisartan [3]. Generally, once primary patents expire, generic versions can enter the market.
What are the potential side effects of Telmisartan?
Common side effects of telmisartan include dizziness, lightheadedness, fatigue, and a possible sore throat or cough [1]. Less common but more serious side effects can include kidney problems, high potassium levels, and a severe allergic reaction [1].
Can generic Telmisartan be manufactured at a lower cost?
Generic drug manufacturing typically aims for lower production costs compared to brand-name drugs due to factors such as reduced research and development expenses and competition among multiple manufacturers [4]. These efficiencies often translate to lower prices for consumers once the patents expire and generic versions become available.